ABSTRACT-Using various models of acute renal failure (ARF) in rats, the diuretic effects of 8 (noradamantan-3-yl)-1, 3-dipropylxanthine (KW-3902), a novel adenosine A,-receptor antagonist (0.01 and 0.1 mg/kg, p.o.), were determined and compared with those of furosemide (30 mg/kg, p.o.) and trichlormethiazide (TCM; 1 mg/kg, p.o.). In cisplatin-induced ARF rats, KW-3902 and TCM, but not furosemide, increased Na excretion. KW-3902 did not affect creatinine clearance (CORE), while TCM de creased CCRE. In gentamicin-induced ARF rats, KW-3902 increased urine volume (UV) and Na excretion. In glycerol-induced oliguric ARF rats, KW-3902, but not furosemide or TCM, increased UV, Na and K excre tion and tended to improve the depressed CCRE, suggesting that the improvement of renal hemodynamics might also contribute to the diuretic effect of KW-3902. In glycerol-induced polyuric ARF rats, only KW 3902 significantly increased UV and Na excretion. These results demonstrate that KW-3902 induces natriuretic effects in various models of ARF and that the effect of KW-3902 is more prominent than those of furosemide and TCM. The present results suggest that endogenous adenosine may be involved in various forms of ARF via adenosine A,-receptors.
Diuretics are clinically prescribed for the treatment of edema associated with congestive heart failure, hepatic cir rhosis and various renal diseases. However, when diuret ics are used for the patients with renal diseases, especially for those with acute or chronic renal failures, their effi cacy cannot sufficiently be achieved in many cases, because the renal tubule, or the site of action of diuretics, is damaged in such patients (1) . Acute renal failures (ARF) are classified into two types: the oliguric one that shows oliguria, and the non-oliguric one that maintains a uri nary volume of more than 500 ml/day but exhibits a rise in serum creatinine (S-CRE). Patients with oliguric renal failures usually are treated with diuretics, such as loop diuretics or mannitol, for accelerating urination, since thiazides, aldosterone antagonists and carbonic anhy drase inhibitors are scarcely effective in such patients in general (2) . Some investigators have suggested that therapy with furosemide in large doses may significantly improve the clinical course of acute renal failure (3, 4) , although such therapy sometimes causes side effects, such as loss of hearing.
KW-3902 (8-(noradamantan-3-yl)-1, 3-dipropylxan thine) is a newly synthesized and selective adenosine A, receptor antagonist, which is the most potent one report ed to date (5) . In the receptor-binding study, the dissocia tion constant values of KW-3902 for adenosine A,-recep tor and A2-receptor are 1.3 nM and 380 nM, respectively (5, 6) . In anesthetized rats, KW-3902 antagonizes the 5' N-ethycarboxamidoadenosine (NECA)-induced bradycar dic response mediated via adenosine A,-receptors, with lit tle influence on the NECA-induced hypotensive response mediated via adenosine A2-receptors (7). In saline-loaded normal rats, blockade of adenosine A,-receptors with KW-3902 induces significant increases of urine volume and sodium excretion with little change of potassium ex cretion (7, 8) . From the results of a Li clearance study and the stop-flow method, KW-3902 is assumed to act mainly on the proximal tubule, resulting in diuresis and natri uresis (8) . Additionally, we previously reported that KW 3902 possesses renal protective effects against glycerol or cisplatin-induced ARF (7, 9) . Thus, the diuretic and renal protective effects of KW-3902 have been ascribed to the blockade of adenosine A,-receptors.
In the present study, to examine the effects of diuretics on the established ARF, the diuretic effects of KW-3902 were determined and compared with those of furosemide and trichlormethiazide (TCM) in rats with ARF induced by cisplatin, gentamicin or glycerol.
MATERIALS AND METHODS

Animals
Male Wistar rats, weighing 170-300 g (Japan Shizuoka Laboratory Animal Center, Inc., Hamamatsu), were used in the present study. All animals received humane care in compliance with the "Guiding Principles for the Care and Use of Laboratory Animals" formulated by the Japanese Pharmacological Society and the protocol was approved by the Bioethical Committee of Pharmaceutical Research Laboratories, Kyowa Hakko Kogyo Co., Ltd. The animals were kept at 22V with a 12-hr light-dark cycle. They had free access to tap water and commercial chow.
Drugs used
KW-3902 (8-(noradamantan-3-yl)-1,3-dipropylxanthine) and furosemide were synthesized in our laboratories. TCM and gentamicin sulfate were purchased from Sigma Chemical Co. (St. Louis, MO, USA). Cisplatin (Randa`') was purchased from Nihon Kayaku Co., Ltd. (Tokyo). All other chemicals and solvents were used in their analyti cally pure form. For oral administration, KW-3902 (0.01 and 0.1 mg/kg), furosemide (30 mg/kg) and TCM (1 mg/kg) were suspended in saline containing 0.05% Tween 80.
Diuretic effects in normal rats
Diuretic effects of drugs in normal rats were determined with a slight modification of the previous method (10) . In brief, rats were fasted for 18 hr, and the drug suspension or the vehicle was orally administered to the rat at a volume of 25 ml/kg. After the administration, the rats were housed individually in metabolic cages without food and water. Urine was collected for 4 hr, and its volume was measured. The concentrations of sodium and potas sium in the urine were measured by a flame photometer (775-A; Hitachi Ltd., Tokyo), and the urinary excretions of sodium and potassium were calculated.
Induction of ARF
Cisplatin-induced ARF: Cisplatin-induced ARF was produced according to the previous method (11) . Cispla tin at 4 mg/kg was intravenously injected to rats through the tail vein. Ninety-six hours after the cisplatin injection, the rats, which had been fasted for 18 hr, were used for the experiment. Gentamicin-induced ARF: The gentamicin-induced ARF was produced by the previously described method (12) . Gentamicin sulfate was injected subcutaneously to rats at 200 mg/kg/day for 5 days. On the 9th day from the beginning of the administration, the rats, which had been fasted for 18 hr, were used for the experiment.
Glycerol-induced ARF (oliguric model): Glycerol-in duced ARF was produced by the previously described method (13 -15) . To rats kept away from water over night, 50070 (v/v) glycerol was subcutaneously injected at 8 ml/kg under ether anesthesia. Ninety minutes after glycerol injection, 10 ml/kg of water was given orally, and the experiment was started 3 hr later.
Glycerol-induced ARF (polyuric model): The rats were injected with glycerol as described above. For 6 hr after the glycerol administration, the rats had free access to tap water and commercial chow. Twenty four hours later, the rats, which had been fasted for 18 hr, were used for the ex periment.
Diuretic effects in rats with ARF
Before the evaluation of the diuretic effect in each ARF rat, a blood sample was collected from the tail vein, and S-CRE was measured with an autoanalyzer (AU510; Olympus, Tokyo). From the obtained value of S-CRE, an index of renal failure, the rats were divided into 5 groups, and the diuretic effects of the test compound were deter mined in the same way as described for the normal rats. After obtaining urine, the blood was collected from the abdominal descending aorta under ether anesthesia, and the serum was separated. S-CRE, serum urea nitrogen (S-UN) and urinary creatinine (U-CRE) were measured with the autoanalyzer. As an index of glomerular filtration rate (GFR), creatinine clearance (CORE), was calculated by the following standard formula:
Preparation and staining of renal tissue slices
The left kidney in the control group of each ARF model was excised for histopathological examination. The excised kidney was fixed in 10070-formalin-buffered solution (pH 7.25), embedded in paraffin routinely and sliced about 3 im in thickness by a microtome. After they were stained with hematoxylin/eosin, the slices were ob served under an optical microscope (FX-A model; Nikon, Tokyo).
Statistic analyses
All the results are given as means±S.E. To define statistically significant differences among the groups, the data were subjected to Student's t, the Aspin-Welch test, or analysis of variance (ANOVA) followed by the Dun nett or Steel test. A P value of less than 0.05 was consi dered to be statistically significant. Rats with cisplatin-induced ARF Intravenous injection of cisplatin at 4 mg/kg sig nificantly increased S-CRE and S-UN and nearly halved CCRE. Treatment with cisplatin had no influence on the urinary volume but decreased potassium excretion. The histopathological examination revealed damages at the renal cortico-medullary junction following the administra tion of cisplatin in rats. The cortico-medullary junction includes the straight portion of the proximal tubule, Henle's loop, the straight portion of the distal tubule, and the collecting duct. Focal necrosis and degeneration of tubular epithelium were observed mainly at the proximal tubule (Fig. 1) . Table 2 shows the effects of the test compounds in rats with cisplatin-induced ARF. TCM significantly increased urinary volume. KW-3902 and TCM significantly in creased sodium excretion; however, potassium excretion was significantly increased only with TCM. The Na/K ratio was significantly elevated following the injection of cisplatin, and this was further elevated by the administra tion of KW-3902 at 0.01 mg/kg. All three compounds scarcely influenced S-CRE and S-UN. CCRE scarcely changed in the KW-3902 group, tended to fall in the furosemide group and significantly fell in the TCM group, as compared with the control group.
RESULTS
Diuretic effects in normal rats
Rats with gentamicin-induced ARF Subcutaneous consecutive administration of gentami cin (200 mg/kg/day) for 5 days significantly increased S CRE and S-UN and reduced CCRE to about 115. Gentami cin increased urinary volume but decreased sodium excre tion. In the histological examination, epithelial necrosis and degeneration were observed at the proximal tubule and at a part of the distal tubule, respectively (Fig. 1) . Sig nificant necrosis or degeneration was not observed at the glomerular area. Table 3 shows the effects of the test compounds. Only KW-3902 significantly increased urinary volume and so dium excretion. The Na/K ratio, which had been signifi cantly reduced following the injection of gentamicin, was significantly increased by the administration of KW-3902. None of the compounds had any significant influence on S-CRE, S-UN or CCRE.
Rats with glycerol-induced ARF (oliguric model)
In 3 of 7 rats of the control group, no urine was excret ed during the experiment, indicating that the oliguric con dition was induced. Thus, CCRE apparently became nearly zero. In the histological examination, eosinophilic materi als formed casts in the tubular lumen. At the tubular epithelium, the increase of hyalin droplets was observed, and degeneration and necrosis were observed focally. At the glomerular area, congestion of the capillary was ob served (Fig. 1) . Table 4 shows the effects of the test compounds in rats with glycerol-induced oliguric ARF. Urinary volume in the rat treated with KW-3902 was significantly increased, almost to that in normal rats. KW-3902 significantly in creased sodium excretion and, at the same time, it also in creased potassium excretion. In the rats treated with KW 3902 at 0.1 mg/kg, the increase of S-CRE and S-UN was significantly attenuated. CCRE was significantly increased in the rats treated with KW-3902' at 0.01 mg/kg. On the other hand, the diuretic effects of furosemide and TCM were slight, although in the rats treated with furosemide, the increase of S-CRE was significantly attenuated.
Rats with glycerol-induced ARF (polyuric model)
At 24 hr after subcutaneous injection of glycerol, S CRE and S-UN significantly increased, and CCRE fell to about 1/10. Urinary volume and sodium excretion were increased by the glycerol administration. In the histologi cal examination, no significant change was observed at the glomerular area; however, degeneration was widely scattered at the renal tubule (Fig. 1) . Especially, epithelial necrosis and protein casts were observed at the proximal tubule in the whole cortical area. Table 5 shows the effects of the test compounds in rats with glycerol-induced ARF. KW-3902 significantly in creased urinary volume, whereas furosemide and TCM did not alter urinary volume. KW-3902 significantly in creased sodium excretion; and the Na/K ratio, which had significantly been increased following the glycerol injec tion, was further increased by the KW-3902 administra tion. None of the compounds had any significant influence on S-CRE, S-UN or CORE. Table 3 . Effects of KW-3902, furosemide and trichlormethiazide (TCM) in rats with gentamicin-induced acute renal failure Table 4 . Effects of KW-3902, furosemide and trichlormethiazide (TCM) in rats with glycerol-induced acute renal failure (oliguric model) 
DISCUSSION
Large doses of furosemide are used to produce diuresis in patients with ARF associated with advanced renal dysfunction, whereas Epstein et al. (16) reported that furosemide did not improve renal function and renal hemodynamics. On the other hand, Greven and Klein (17) reported that the glycerol-induced renal failure in rats was rather aggravated with furosemide. The present study demonstrated that in various models of ARF, KW-3902 induces the natriuretic effect, which is more prominent than those of furosemide and TCM.
Cisplatin is commonly used as an anticancer agent for the treatment of solid tumors (18) . It is known that the high dose of cisplatin frequently causes ARF as its side effect (19) . In the present study, only TCM was found to have a significant diuretic effect in the rats with cisplatin induced ARF, though this drug significantly decreased CCRE. The present observation is in accordance with the previous report that hydrochlothiazide decreased renal blood flow in ischemic ARF (20) .
It is reported that the methylxanthine aminophylline ameliorated the cisplatin nephrotoxicity when admin istered to the rat during the maintenance phase of acute tubular necrosis (11) . Moreover, KW-3902 exhibit ed renal protective effects against cisplatin-induced ARF (9) . These results suggest that adenosine may be involved in cisplatin-induced nephrotoxicity via adenosine A1 receptors. In the present study using the rats with estab lished cisplatin induced ARF, KW-3902 produced a sig nificant natriuresis without any effect on CCRE, although the increase in urinary volume was not statistically sig nificant. It is, therefore, assumed that KW-3902 produced a natriuretic effect via the blockade of adenosine A1-recep tors.
Gentamicin is an aminosaccharide antibiotic, which oc casionally causes ARF as its side effect (21) . In the rats with gentamicin-induced ARF, KW-3902, but not furosemide or TCM significantly increased the urinary volume. Furosemide was reported to enhance gentamicin nephrotoxicity because this drug directly accelerates gen tamicin accumulation in renal tissues (22) . In contrast, KW-3902 possesses a renal protective effect against gen tamicin-induced ARF (K. Yao et al., unpublished data). It is therefore likely that KW-3902 is more useful as a di uretic than furosemide or TCM under the treatment of gentamicin.
The intramuscular or subcutaneous injection of glycerol causes regional myolysis and hemolysis, leading to ARF through the contraction of renal vessels (23) . In this model, the damage is severe, and, moreover, degen eration occurs in a wide range of renal tubules. Therefore, the diuretics having the site of action only at the renal tub ule may be less effective in inducing diuresis. It was report ed that the adenosine antagonist 8-phenyltheophylline induces a marked diuretic effect in the glycerol-induced ARF, whereas hydrochlorothiazide does not cause diure sis (24). The absence of a diuretic effect of thiazide in this type of ARF has been suggested to be due to the fact that the impairment of tubular sodium reabsorption was al ready present in the ARF. In the present study, KW-3902 had significant diuretic effects in both the oliguric and the polyuric models, whereas furosemide and TCM showed minimal diuretic effects. Moreover, KW-3902, but not furosemide or TCM, significantly increased CCRE in the oliguric model. These results suggest that KW-3902 may possibly have a site of action other than the renal tubule or have another mechanism of action to induce diuresis.
One of the actions of KW-3902 different from those of furosemide and TCM was its influence on CCRE. The ad ministration of furosemide did not affect CCRE in any ARF models of the present study. The administration of TCM reduced CCRE in the cisplatin-induced ARF, while KW-3902 had no influence on CcRE. In the glycerol-in duced oliguric ARF, KW-3902 increased CCRE, suggesting an improvement of the renal function. In the glycerol-in duced ARF, adenosine is suggested to constrict the affer ent arterioles, leading to the depressed CCRE, since the out flow of adenosine from the renal vein is increased after the glycerol-injection (25). If so, KW-3902 might have im proved the CCRE via the blockade of A,-adenosine recep tors, the stimulation of which is known to constrict the afferent arterioles (26). The present results suggest that the renal hemodynamic effect is at least partly involved in the diuretic action of KW-3902 in the glycerol-induced ARF.
In case of clinical ARF, the characteristics of diuretic use have not yet been established. In the present experi ment, cisplatin, gentamicin and glycerol increased S-CRE and S-UN, but any of the diuretic drugs tested had little influence on such increases. However, in the glycerol-in duced oliguric ARF, KW-3902 inhibited the elevation of S-CRE and S-UN, and improved CCRE, indicating a pro tective effect against the aggravation of ARF. This may be due to the fact that the experiment was conducted in the model of ARF in progress. In fact, prophylactic adminis tration of KW-3902 protects against glycerol-induced ARF (7) . The protective effect of KW-3902 against the aggravation of ARF has been assumed to be due to the adenosine A,-receptor blockade. The precise role of adenosine in renal failure or renal dysfunction remains un clear, and further investigations are necessary.
In conclusion, the present study demonstrated that KW-3902 exhibits a natriuretic effect even in various ARF models without deteriorating the renal functions. The present results suggest that endogenous adenosine may be involved in various forms of ARF via adenosine A,-recep tors.
